Workflow
PepsiCo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2026-02-03 07:02
PepsiCo, Inc. (NASDAQ:PEP) will release earnings for its fourth quarter before the opening bell on Tuesday, Feb. 3.Analysts expect the company to report quarterly earnings of $2.24 per share. That's up from $1.96 per share in the year-ago period. The consensus estimate for PepsiCo’s quarterly revenue is $28.97 billion (it reported $27.78 billion last year), according to Benzinga Pro.On Jan. 6, PepsiCo announced a collaboration with Siemens and NVIDIA to transform plant and supply chain operations through ad ...
Elis: Disclosure of trading in own shares occured from January 26 to January 30, 2026
Globenewswire· 2026-02-03 07:00
Disclosure of trading in own shares occurred from January 26 to January 30, 2026 Puteaux, February 3, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from January 26 to January 30, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily total Volume (in n ...
62,752 Orion Corporation A shares converted into B shares
Globenewswire· 2026-02-03 07:00
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 3 FEBRUARY 2026 at 9.00 EET         62,752 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 62,752 A shares have been converted into 62,752 B shares. The conversion has been entered into the Trade Register on 3 February 2026. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, ...
AudioCodes Reports Fourth Quarter and Full Year 2025 Results and Declares Semi-Annual Dividend of 20 cents per share
Prnewswire· 2026-02-03 07:00
OR YEHUDA, Israel, Feb. 3, 2026 /PRNewswire/ -- Fourth Quarter and Full Year 2025 Highlights Details AudioCodes (NASDAQ: AUDC), a global leader in enterprise voice and VoiceAI business solutions, today announced its financial results for the fourth quarter and full year period ended December 31, 2025. Revenues for the fourth quarter of 2025 were $62.6 million compared to $61.6 million for the fourth quarter of 2024. Revenues were $245.6 million in 2025 compared to $242.2 million in 2024. EBITDA for the four ...
Zelluna promotes Emilie Gauthy to Chief Technology Officer
Globenewswire· 2026-02-03 07:00
Core Insights - Zelluna has promoted Emilie Gauthy to Chief Technology Officer (CTO), effective immediately, recognizing her contributions to the company's manufacturing and CMC capabilities since joining in 2022 [1][4] Company Developments - As CTO, Gauthy will lead Zelluna's manufacturing and CMC strategy, focusing on advancing the clinical development program, scaling up manufacturing capacity, and expanding the TCR-NK pipeline [2] - Under Gauthy's leadership, Zelluna has established a scalable manufacturing process and analytical capabilities, which facilitated the submission of its Clinical Trial Application (CTA) for ZI-MA4-1 to the UK MHRA in December 2025 [3] - Key achievements include locking the manufacturing process, producing and quality-testing a GMP clinical batch, and establishing the CMC foundation for the first-in-human clinical trial, with initial data expected from mid-2026 [3] Leadership Statements - CEO Namir Hassan highlighted Gauthy's central role in building the manufacturing and CMC capabilities that enabled the submission of the first CTA, emphasizing her leadership in establishing the foundation for clinical development [4] - Emilie Gauthy expressed pride in the team's achievements since 2022, noting the submission of the first CTA as a major milestone and the strong manufacturing foundations built for the scalable TCR-NK platform [4] Company Overview - Zelluna ASA is pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for solid cancers, with its lead candidate ZI-MA4-1 being the world's first MAGE-A4 targeting TCR-NK therapy [5] - The company submitted its Clinical Trial Application to the UK MHRA in December 2025, with initial clinical data expected to emerge from mid-2026 [5]
AS Tallink Grupp Statistics for January 2026
Globenewswire· 2026-02-03 07:00
Group 1: Passenger and Cargo Transport Performance - In January 2026, AS Tallink Grupp transported 337,926 passengers, marking a 12.6% increase from January 2025 [1] - The number of cargo units transported increased by 18.0% to 22,411 units compared to the same period last year [1] - The number of passenger vehicles rose by 9.6% to 47,813 units compared to January 2025 [1] Group 2: Route-Specific Performance - Finland-Sweden route saw 77,052 passengers, a 12.4% increase from 68,579 passengers in January 2025, despite the Silja Symphony being out of service for 22 days due to maintenance [2] - Estonia-Finland route recorded 225,791 passengers, reflecting a 14.5% increase from 197,213 passengers in January 2025, with operations involving MyStar, Megastar, and Victoria I [3] - Estonia-Sweden route had 35,083 passengers, a 2.6% increase from 34,199 passengers in January 2025, with services provided by Baltic Queen and Superfast IX [4] Group 3: Detailed Cargo and Vehicle Statistics - Cargo units on the Finland-Sweden route increased by 5.5% to 2,493 units, while Estonia-Finland route saw a significant rise of 22.9% to 17,399 units [1][2][3] - Passenger vehicles on the Finland-Sweden route increased by 15.8% to 2,939 units, while Estonia-Finland route recorded an 8.6% increase to 42,950 units [1][3] - The Estonia-Sweden route experienced a notable 25.6% increase in passenger vehicles, totaling 1,924 units [1][4]
2026 Financial Calendar
Globenewswire· 2026-02-03 07:00
3 February 2026 News Release Pharma Equity Group2026 Financial Calendar ​March 4Deadline for shareholder proposals - Annual General meeting​ ​March 18 ​Annual Report 2025​ April 16Annual General Meeting​ August 14Interim Report – for the six-month period ended June 30. 2026​ ​Contact person – Investor Relations On the Company’s website www.pharmaequitygroup.com further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directe ...
RTX's Collins Aerospace and All Nippon Airways renew FlightSense™ and MRO contracts
Prnewswire· 2026-02-03 07:00
About Collins Aerospace Agreements provide services for engine accessories and power and controls components SINGAPORE, Feb. 3, 2026 /PRNewswire/ -- Collins Aerospace, an RTX business (NYSE: RTX), and All Nippon Airways (ANA) have signed two separate FlightSenseâ"¢ renewal agreements today in a signing ceremony at the Singapore Air Show. The first FlightSense contract is a five-year renewal for on-site support for the airline's Boeing fleet of 737NG/MAX, 767, 777, 787 aircraft as well as its De Havilland Ca ...
IVES: Too Risky In This Tech-Heavy Market (Rating Downgrade)
Seeking Alpha· 2026-02-03 06:54
Core Viewpoint - The article discusses the Dan Ives Wedbush AI Revolution ETF (IVES) and highlights the reputation of Dan Ives as a prominent tech analyst [1]. Group 1 - Dan Ives is recognized for his distinctive style and expertise in technology analysis [1]. - The review of the ETF was initially conducted in August, indicating ongoing interest in AI-related investments [1].
Nintendo keeps its full-year sales guidance as Switch 2 momentum continues
CNBC· 2026-02-03 06:48
Core Viewpoint - Nintendo's Switch 2 launch has generated significant consumer interest, but the company faces challenges in sustaining momentum and managing costs [1][4]. Financial Performance - For the fiscal third quarter ended December 31, Nintendo reported revenue of 806.32 billion Japanese yen ($5.2 billion), which was below the expected 847.73 billion yen [6]. - The net profit for the same period was 159.93 billion yen, exceeding the expected 147.3 billion yen [6]. Sales Forecast - Nintendo maintained its sales forecast for the Switch 2 at 19 million units for the fiscal year ending March 2026, an increase from the previous forecast of 15 million units [2]. Stock Performance - Following the Switch 2 launch in June, Nintendo's share price reached a record high above 14,000 yen in August, but has since declined by more than 30% [3]. Market Challenges - Investors are concerned about potential headwinds, including rising memory prices, which are crucial for console production, and the adequacy of Nintendo's game pipeline to support the Switch 2 [4].